Physician profile
Suzanne Young
NPI 1942353644
$1,465.11
in general payments reported to CMS, 2019-2025
19 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $209 · 2023: $504 · 2024: $274 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.75 | 2021-2025 | |
| Glaxosmithkline, LLC. | $283.34 | 2021-2023 | Arexvy, Rotarix, Bexsero |
| Amgen INC. | $128.71 | 2022-2023 | Repatha |
| Lilly USA, LLC | $81.17 | 2021-2023 | Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.34 | 2025 | Caplyta |
| Indivior INC. | $50.71 | 2025 | Sublocade |
| Novo Nordisk INC | $46.47 | 2023-2025 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $45.06 | 2023-2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $39.77 | 2023-2024 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $34.52 | 2024 | Airsupra |
| Dexcom, INC. | $34.08 | 2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $33.08 | 2021-2025 | |
| Corcept Therapeutics | $29.91 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $28.65 | 2024-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Organon LLC | $28.57 | 2025 | Nexplanon |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $28.09 | 2021 | |
| Hologic Sales and Service, LLC | $17.87 | 2022 | |
| Masimo Corporation | $17.57 | 2023 | Bridge |
| Bausch Health US, LLC | $16.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.